stanley erck / Заголовки новостей 
NVAX Stock Up Nearly 16% in Pre-market as Novavax Starts Coronavirus Vaccine Trials
Coinspeaker NVAX Stock Up Nearly 16% in Pre-market as Novavax Starts Coronavirus Vaccine TrialsNovavax (NVAX) has jumped by 16% in the pre-market. The company has announced human trials its COVID-19 vaccine. дальше »
2020-5-27 16:21
|